Evidence map›Paper›PMID 35658489›Full record

ArticleAntimicrobial agents and chemotherapy2022

Preparation of Decoquinate Solid Dispersion by Hot-Melt Extrusion as an Oral Dosage Form Targeting Liver-Stage

Hongxing Wang, Yinzhou Fan, Li Qin, Zhipeng Cheng, Xueqing Chen, Sumei Zeng, Shuanghong Liang, Ying Tong, Zhu Tao, Yucheng Liu and 5 more

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. SoluplusInternational journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Hongxing WangDivision of Nanomedicine, Bluelight Pharmatech, Co., LTD, Guangzhou, China.ORCID 0000-0002-7583-6190
Yinzhou FanDivision of Nanomedicine, Bluelight Pharmatech, Co., LTD, Guangzhou, China.
Li QinCAS Lamvac Biotech Co., Guangzhou, China.
Zhipeng ChengCAS Lamvac Biotech Co., Guangzhou, China.
Xueqing ChenDivision of Nanomedicine, Bluelight Pharmatech, Co., LTD, Guangzhou, China.
Sumei ZengDivision of Nanomedicine, Bluelight Pharmatech, Co., LTD, Guangzhou, China.
Shuanghong LiangDivision of Nanomedicine, Bluelight Pharmatech, Co., LTD, Guangzhou, China.
Ying TongCAS Lamvac Biotech Co., Guangzhou, China.
Zhu TaoCAS Lamvac Biotech Co., Guangzhou, China.
Yucheng LiuCAS Lamvac Biotech Co., Guangzhou, China.
Xiaorong LiuThe Drug Discovery Pipeline, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Xiaohui NingDivision of Nanomedicine, Bluelight Pharmatech, Co., LTD, Guangzhou, China.
Peiquan ChenCAS Lamvac Biotech Co., Guangzhou, China.
Siting ZhaoCAS Lamvac Biotech Co., Guangzhou, China.
Xiaoping ChenCAS Lamvac Biotech Co., Guangzhou, China.
Guangzhou Institutes of Biomedicine and Health · CNChinese Academy of Sciences · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver-stage

Indexed as

AntimalarialsDecoquinateMalariaAnimalsDrug CompoundingHot TemperatureLiverMicePlasmodium bergheiRatsSolubilityAntimalarialsDecoquinatehot-melt extrusionliver stagenanoparticlespharmaceutical formulationPlasmodiumPlasmodium infection

Identifiers

PMID35658489
PMCPMC9211432
OpenAlexW4281674084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.